Drug: AMBISOME Injury: Renal impairment Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 126162541 | AMBISOME | Renal impairment | ASTELLAS | 35.00 YR | M | 0 | 20160802 | US |
| 126688081 | AMBISOME | Renal impairment | ASTELLAS | 0.00 | M | 0 | 20160819 | US |
| 127235411 | AMBISOME | Renal impairment | XELLIA PHARMACEUTICALS | 35.00 YR | M | 0 | 20160908 | US |
| 127651241 | AMBISOME | Renal impairment | APOTEX | 12.00 YR | F | 0 | 20160921 | US |
| 127654231 | AMBISOME | Renal impairment | APOTEX | 5.00 YR | F | 0 | 20160921 | US |
| 127845521 | AMBISOME | Renal impairment | SANDOZ | 5.00 YR | F | 0 | 20160927 | US |
| 127872851 | AMBISOME | Renal impairment | SANDOZ | 12.00 YR | F | 0 | 20160928 | US |
Total Records: 7 Number of Pages: 1